Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00208858 · ClinicalTrials.gov registry record · Phase 2
A Pilot Study of the Neural Correlates of Treatment Effect on Nicotine Craving
A Phase 2 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00208858: Completed Phase 2 study, sponsored by Emory University.
NCT00208858 is a Phase 2 study that has completed, run by Emory University. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00208858, a Phase 2 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this study is to gather pilot data to determine feasibility of and guide the development of a larger clinical trial investigating the effects of topiramate as an adjunct to nicotine replacement therapy and behavioral counseling in smoking cessation treatment. It is hypothesized that topiramate will decrease nicotine craving and result in improved outcomes for smoking cessation.
Interventions
- DRUG Topiramate
Trial Details
| Field | Value |
|---|---|
| Start Date | 2004-12 |
| Est. Completion | 2006-12 |
| Phase | Phase 2 |
What the finished NCT00208858 record still lists
NCT00208858 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Topiramate is the first listed.
NCT00208858 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00208858 about?
NCT00208858 is a clinical study titled "A Pilot Study of the Neural Correlates of Treatment Effect on Nicotine Craving". The purpose of this study is to gather pilot data to determine feasibility of and guide the development of a larger clinical trial investigating the effects of topiramate as an adjunct to nicotine replacement therapy and behavioral counseling in smoking cessation treatment. It is hypothesized that t...
What is the current status of trial NCT00208858?
This trial is currently completed. It is a Phase 2 study. The study started on 2004-12. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00208858?
The interventions under investigation include: Topiramate (DRUG).
Who is sponsoring clinical trial NCT00208858?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia